Fair Value Disclosures (Tables)

3 Months Ended

Mar. 31, 2026

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured to Fair Value on Recurring Basis

The table below presents the fair values of certain financial assets and liabilities that are measured at fair value on a recurring basis in the Company's financial statements (in thousands).

Description	March 31, 2026		December 31, 2025
Assets:
Values based on Level 1 inputs:
Deferred compensation plan assets (1)	$	23,441	$	19,188
Total Level 1 inputs	23,441		19,188
Values based on Level 2 inputs:
Deferred compensation plan assets (1)	150,417		155,949
Foreign currency forward contracts (2)	213		1,169
Total Level 2 inputs	150,630		157,118
Total Assets	$	174,071	$	176,306
Liabilities:
Values based on Level 2 inputs:
Deferred compensation plan liabilities (1)	$	178,390	$	178,331
Foreign currency forward contracts (2)	212		939
Total Level 2 inputs	178,602		179,270
Total Liabilities	$	178,602	$	179,270

(1)The Company has a deferred compensation plan for the benefit of certain highly compensated officers, managers and other key employees. The assets consist of investments in money market funds, mutual funds and company-owned life insurance contracts, which are valued based on Level 1 or Level 2 inputs. The related deferred compensation plan liabilities are recorded at fair value, or the estimated amount needed to settle the liability, which the Company considers to be a Level 2 input.

(2)The Company enters into foreign currency forward exchange contracts to hedge the effects of adverse fluctuations in foreign currency exchange rates (see Note 11 — Derivatives and Hedging). Valuation of these contracts is based on observable foreign currency exchange rates in active markets, which the Company considers to be a Level 2 input.

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments

The table below presents the carrying amounts (net of deferred financing costs) and fair values of financial instruments that are not recorded at fair value in the Company’s Condensed Consolidated Balance Sheets (in thousands). The estimated fair value of the financial instruments was derived from quoted market prices provided by an independent dealer, which the Company considers to be a Level 2 input.

	Carrying Amount				Fair Value
	March 31,		December 31,		March 31,		December 31,
Description	2026		2025		2026		2025
2028 Notes	$	796,888	$	796,563	$	787,152	$	798,080
2029 Notes	596,811		596,578		564,276		578,760
2030 Notes	795,264		795,024		730,344		759,224
2031 Notes	346,708		346,564		341,674		351,869
2035 Notes	445,498		445,411		426,686		450,657
Total	$	2,981,169	$	2,980,140	$	2,850,132	$	2,938,590